HEPATOLOGY Copvright (c 198.5 by the American Association lor the Stud! ~J I l h e r Di.sea.sea L'ol. 5, NO. 6. pp. 1083-1087, 1%5 Printedin U.S.A.
Does interferon precipitate rejection of liver allografts?
โ Scribed by Albert D. Min; Henry C. Bodenheimer Jr
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 396 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha often leads to allograft rejection. The aim of the
Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RN
The influence of human leukocyte antigen (HLA) on acute liver allograft rejection was investigated in 48 adult patients. The diagnosis of rejection was always based on the full triad of histological findings, clinical signs, and the required antirejection treatment. Sixty-two percent of the patients